
|
ITEM
|
SUPPLIES / SERVICES
|
QTY / UNIT
|
UNIT PRICE
|
EXTENDED PRICE
|
|
0001
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
[**] Doses
|
$[**]
|
$[**]
|
|
Funding in the amount of $125,009,128.00 was provided on the letter notice of award dated September 30, 2011.
|
||||
|
0001A
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0001B
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0001C
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0001D
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
0002
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
[**] Doses
|
$[**]
|
$[**]
|
|
0002A
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0002B
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0002C
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0002D
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
0003
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
[**] Doses
|
$[**]
|
$[**]
|
|
0003A
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0003B
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0003C
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0003D
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
0004
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
[**] Doses
|
$[**]
|
$[**]
|
|
0004A
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0004B
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0004C
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0004D
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
0005
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
[**]Doses
|
$[**]
|
$[**]
|
|
0005A
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0005B
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0005C
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
|
0005D
|
BioThrax [**] product
[**] upon date of delivery
[**]
To be delivered in accordance with the delivery schedule below
|
$[**]
|
$[**]
|
|
a)
|
From a minimum order of [**] doses per order, and at the price stated in the Schedule above, up to the maximum quantity identified for each numbered line item. Each option line item may be exercised more than once, until the cumulative number of doses to be delivered under each option is delivered. The total doses ordered hereunder shall not exceed 44,750,000 doses over the 5 year period of performance, unless changed by formal modification to the contract. Each CLIN, including the alternate CLINs (with the same number and a lettered suffix) collectively function as one option. [**].
|
|
b)
|
[**].
|
|
c)
|
The Contracting Officer may exercise the option by written notice to the Contractor. The Contractor will be notified in writing, by letter or email, at least one (1) business day before the option to acquire more product is exercised. After that written notification, a funded, unilateral modification will be issued to actually exercise the option and order the doses.
|
|
a)
|
The Contractor shall manufacture BioThraxâ in accordance with current Good Manufacturing Practices (cGMP) guidelines. The Contractor shall manufacture 44,750,000 doses of Final Drug Product (FDP) in 5 mL, ten dose vials in accordance with the targeted delivery schedule from October 1, 2011 – September 30, 2016.
|
|
b)
|
BioThrax® shall be delivered on any business day, except Federal holidays, within the scheduled month in accordance with the targeted delivery schedule. Contractor shall notify the Government promptly upon becoming aware of any deviations from the targeted delivery schedule. All changes to the targeted delivery schedule must be approved by the Contracting Officer and/or the Contracting Officer’s Representative (COR).
|
|
c)
|
Quantities for each scheduled delivery shall be of a specific quantity.
|
|
d)
|
The Contractor shall perform all requisite assays and release tests, including but not limited to potency, identity, and stability testing in accordance with the FDA approved Biologic License Application (BLA-License Number 1755, STN 103821, and any approved change).
|
|
e)
|
All BioThraxâ delivered under this contract shall be labeled with an expiration date consistent with its current product license at the time of manufacture.
|
|
f)
|
The Contractor shall provide primary and secondary points of contact who shall be available 24 hours per day, seven days per week to be notified in case of a public health emergency.
|
|
g)
|
The Contractor shall report to the Government material correspondence from the FDA regarding the quality, safety, or efficacy of BioThrax®.
|
|
h)
|
The Contractor shall provide the Government with access to and/or provide copies of the following documents: (1) Form 483s form FDA inspections of Contractor’s Lansing facility, (2) Establishment Inspection Reports (EIRs) from FDA inspections of Contractor’s Lansing facility; (3) Warning Letters relating to BioThrax®; and Contractor’s Annual Safety Report to FDA regarding BioThrax®. These documents will be provided to the Contracting Officer within [**] business days of receipt.
|
|
i)
|
The Government shall be notified of any issues with the safety and efficacy of BioThrax® and/or manufacturing or quality of the FDA-licensed production lines at the Contractor’s Lansing facility within [**] business days of the determination of potential to be reported to FDA.
|
|
j)
|
The Government shall have the option to conduct quarterly inspections of the Contractor’s Lansing facility. Such inspections shall be performed by the COR or the COR’s designee(s).
|
|
k)
|
If the contractor should obtain FDA approval for the manufacture and production of BioThrax® having [**] while under this contract, the Government will accept delivery of those doses with the longer shelf life in addition to doses with a shorter shelf life. Contractor may invoice only for those doses actually delivered under contract in accordance with Section B.
|
|
l)
|
The product shall be delivered in accordance with cGMP (current Good Manufacturing Practices).
|
|
m)
|
At least [**] business days prior to the product being ready for pick up by the SNS, the Contractor shall provide to the Contracting Officer and Contracting Officer’s Representative (COR):
|
|
a.
|
The date the product will be ready for loading on the truck(s) scheduled by the SNS
|
|
b.
|
Physical address of the product pick up location (facility name, address, point of contact name and telephone number)
|
|
c.
|
Certificate(s) of Analysis
|
|
d.
|
FDA Lot Release(s)
|
|
e.
|
Number of pallets, vials, and doses to be loaded
|
|
n)
|
At least [**] hours before each scheduled pick up by the SNS, Contractor shall provide the following to the Contracting Officer and COR:
|
|
a.
|
Packing Slip
|
|
b.
|
Actual number of pallets, vials and doses to be loaded
|
|
c.
|
Diagram of product shipment pallet (how many vials per box, per pallet)
|
|
o)
|
Within [**] business days after delivery, the Government shall provide the Contractor the SNS destination location(s) for the lot(s) delivered.
|
|
p)
|
Within [**] hours after the product has been picked up by the SNS, the Contractor shall provide to the Contracting Officer and COR:
|
|
a.
|
The remaining ambient exposure time letter disclosing accumulated ambient temperature exposure until the point that SNS (or SNS-designated personnel) assumed responsibility for temperature control, per Section E.3, for each lot from the Contractor’s Quality Department. The letter should indicate that the product was manufactured and released in accordance with cGMP and has met all acceptance criteria to allow for Government distribution.
|
|
q)
|
Funds provided shall be paid on a price per doses basis only on those products delivered to the SNS under contract.
|
|
r)
|
Under the CLINs of this contract the products shall have an [**] product. The Contractor shall target [**] of the total [**] remaining when the Government takes delivery of the product. If [**] dated product is approved by the FDA, the product shall have an [**]. The Contractor shall target [**] of the total [**] remaining when the Government takes delivery of the product. In the event that product with lower than targeted [**] should be delivered, product with an [**] greater than or equal to [**] shall be deemed [**] product. A product with an [**] greater than or equal to [**] shall be deemed [**] product. A product with an [**] greater than or equal to [**] shall be deemed [**] product. [**] when the Government takes delivery of the product according to the pricing table and Section B.1in Section B.
|
|
CLIN (includes alternate CLINS)
|
Delivery Period
|
# of Doses
|
|
0001
|
October 1, 2011 to September 30, 2012
|
[**]
|
|
0002
|
October 1, 2012 to September 30, 2013
|
[**]
|
|
0003
|
October 1, 2013 to September 30, 2014
|
[**]
|
|
0004
|
October 1, 2014 to September 30, 2015
|
[**]
|
|
0005
|
October 1, 2015 to September 30, 2016
|
[**]
|
|
a)
|
Pre-award Site Visit: The Government reserves the right to conduct a pre-award site visit of the manufacturing plant.
|
|
b)
|
Site Visits/Audits: The Government shall perform annual site visits/security audits as deemed necessary by the Government throughout the period of performance of the contract.
|
|
c)
|
Quality: The Government may visit the Lansing site for purposes of assessing quality on an annual basis or as deemed necessary by the Government throughout the period of performance of the contract.
|
|
d)
|
The contractor shall facilitate cGMP site-visit or inspection as requested by FDA/CBER at the time of production of product lots destined for the SNS.
|
|
e)
|
Quality Management System (QMS): Contractor shall submit evidence of its QMS to the Contracting Officer within 90 days after contract award.
|
|
f)
|
Notice: The Government shall provide 2 weeks advance notice prior to the Contractor of all site visits and audits. The notice will include a statement concerning the intended scope of the audit and a list of the required documents or access to personnel.
|
|
g)
|
All audits shall be conducted between normal business hours i.e. 8 a.m. through 4 p.m., Monday through Friday.
|
|
a)
|
The contractor shall participate in a quarterly meeting (teleconference and/or face-to-face) to discuss performance under the contract. These meetings should provide status updates and discuss on-going manufacturing, clinical, regulatory, and shipment issues as applicable. These meetings shall be coordinated by the COR and/or Contracting Officer
|
|
b)
|
Risk Mitigation Plan: The plan should identify manufacturing, quality, regulatory, and shipment risks and countermeasures to mitigate these risks. This report should be updated annually or as deemed necessary by the USG.
|
|
c)
|
Additional reporting requirements:
|
|
1.
|
Contractor shall notify DSNS in its quarterly reports if Contractor undertakes post-marketing commitments for Phase 4 studies in the event of emergency use authorization.
|
|
2.
|
Contractor shall provide DSNS with drafts of supplements to its BLA for BioThrax® that are material to the manufactured product and to the contract.
|
|
FAR SOURCE
|
TITLE AND DATE
|
|
52.246-1
|
Contractor Inspection Requirements (Apr 1984)
|
|
52.246-2
|
Inspection of Supplies – Fixed Price (Aug 1996)
|
|
52.246-16
|
Responsibility for Supplies (Apr 1984)
|
|
|
(1) Within a reasonable time after the defect was discovered or should have been discovered; and
|
|
|
(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.
|
|
a.
|
Notification of practices that may impact DSNS shipping procedures, if applicable
|
|
b.
|
All items outlined in Section F.3.
|
|
1)
|
Contractor shall deliver to the Government, via e-mail or facsimile:
|
|
a)
|
All required documentation outlined in Sections F.3.2
|
|
b)
|
Notification of the date and time that the product was delivered (Picked Up by the Government or Delivered In Place).
|
|
2)
|
Acceptance Timeframe: The Government shall have [**] full business days, after receipt of all documentation required per Section E.4.1.1), to establish that the requirements of Section E.5 have been satisfied and provide Contractor notice that SNS accepts the lot(s).
|
|
a)
|
For purposes of this acceptance timeframe, business days are defined as 9:00AM to 5:00PM Eastern Time, Monday through Friday, excluding U.S. Government Holidays.
|
|
b)
|
For the avoidance of doubt, DSNS shall provide the Contractor with a written acceptance or refusal of BioThrax® lot(s) no later than 5:00PM on the [**] business day after receipt of the documentation.
|
|
1)
|
The Contractor shall request consent from the COR for Contractor delivery under this option at least [**] days prior to the planned delivery time so that arrangements can be made to accept delivery. If possible, the Contracting Officer shall provide Contractor with the SNS location and point of contact information for the delivery [**] days prior to delivery to the SNS.
|
|
2)
|
At least [**] hours prior to delivery to the SNS, Contractor shall provide to the Government:
|
|
a)
|
Certificate(s) of Analysis
|
|
b)
|
FDA Lot Releases
|
|
c)
|
Number of pallets, vials and doses to be delivered
|
|
d)
|
Name of Security Representative who will be accompanying the delivery
|
|
e)
|
Estimated Time of Arrival for the delivery at the SNS location
|
|
3)
|
With each shipment, contractor will provide:
|
|
a)
|
Bill of Lading
|
|
b)
|
Packing Slip
|
|
c)
|
Shipping Directives
|
|
d)
|
Contractor’s shipping instructions for Drivers
|
|
e)
|
Identification Number for truck(s)
|
|
f)
|
Diagram of product shipment pallet (how many vials per box, per pallet and positioning in truck(s) )
|
|
4)
|
Within [**] business days after delivery, Contractor shall provide to the Contracting Officer:
|
|
a)
|
Confirmation from the Contractor’s Quality Department that the product remained within the acceptable temperature ranges during shipping.
|
|
b)
|
The remaining ambient exposure time for each lot from the Contractor’s Quality Department.
|
|
c)
|
Post-Transit product delivery checklist
|
|
5)
|
Acceptance Timeframe: Following the receipt of the lot distribution documentation in Section E.4.2 parts 1 through 4 (“Documentation”) from the Contractor, DSNS will have a maximum of [**] business days to provide written notification to Contractor of acceptance or refusal of the delivered BioThrax lot(s). Contractor shall provide DSNS the Documentation via email or facsimile. If the Documentation is sent by the Contractor and received by DSNS prior to 9:00AM on a given business day, the tolling of the [**] allotted business days set forth in the acceptance timeframe shall begin on that business day. If the Documentation is sent by Contractor and received by DSNS after 9:00AM on a given business day, the tolling of the [**] business days set forth in the acceptance timeframe will begin on the next business day.
|
|
a)
|
For purposes of this acceptance timeframe, business days are defined as 9:00AM to 5:00PM Eastern Time, Monday through Friday, excluding U.S. Government Holidays.
|
|
b)
|
For the avoidance of doubt, DSNS shall provide the Contractor with a written acceptance or refusal of BioThrax® lot(s) no later than 5:00PM on the [**] business day after receipt of the documentation.
|
|
Temperature Range
|
Action
|
|
< [**]°C
|
· AVA Pallet will be placed into DSNS quarantine pending further disposition
|
|
[**]°C
|
· Acceptable for use by the SNS
|
|
[**]°C
|
· AVA Pallet will be placed into DSNS quarantine
· Release of product by QCU will be pending quality disposition investigation, and remaining ambient exposure for the lot
|
|
>[**]°C
|
· AVA Pallet will be placed into DSNS quarantine pending further disposition
|
|
FAR SOURCE
|
TITLE AND DATE
|
|
52.211-17
|
Delivery of Excess Quantities (Sept 1989)
|
|
52.242-15
|
Stop-Work Order (Aug 1989)
|
|
52.242-15 Alternate I
|
Stop-Work Order - Alternate I (Apr 1984)
|
|
52.242-17
|
Government Delay of Work (Apr 1984)
|
|
52.247-30
|
FOB Origin, Contractor’s Facility (Feb 2006)
|
|
a)
|
The delivery of BioThrax® product shall be F.O.B Origin at the Contractor designated pick up location.
|
|
b)
|
The place of product pick up by the SNS will be provided by the Contractor to the Contracting Officer and COR at least [**] business days prior to scheduled pick up.
|
|
c)
|
Contractor may provide a Delivery-In-Place service, fulfilling the requirements of a F.O.B Origin delivery by meeting the following requirements:
|
|
a.
|
Contractor shall store lot(s) to be delivered in a validated [**]°C storage facility at no additional cost to the Government for pick-up at the next scheduled delivery or [**] days after the Delivery-In-Place acceptance date, (as scheduled by the SNS), whichever comes first.
|
|
b.
|
Contractor shall submit all lot documentation as required under Section F.3.2 below for the lot(s) to be delivered.
|
|
i.
|
Pre-notification deadlines under Section F.3.2 shall not apply for Delivery-In-Place services.
|
|
ii.
|
Once Contractor has provided these documents, the Government’s evaluation of these documents will be completed in accordance with Section E.4.1 above.
|
|
c.
|
Contractor maintains responsibility for temperature control until lot(s) leave the validated [**]°C storage facility per Section E.3 above.
|
|
d.
|
Contractor maintains responsibility for physical integrity of lot(s) until they are placed onto the SNS designated carrier per Section E.3 above.
|
|
a)
|
If agreed to by the COR and/or CO in accordance with clause E.4.2, the delivery of BioThrax® product shall be F.O.B Destination at the SNS designated delivery location.
|
|
b)
|
The place of product delivery to the SNS will be provided by the Contracting Officer to the Contractor at least [**] days prior to scheduled pick up.
|
|
c)
|
Contractor shall ensure lot(s) are delivered via a validated [**]°C carrier at no additional cost to the Government.
|
|
d)
|
Each BioThrax lot will be shipped to the SNS with [**] temperature monitoring devices TempTale(s) assigned for the purpose of recording ambient temperatures during shipment until the point of delivery. The temperatures recorded by the TempTale(s) will be the only temperatures analyzed to determine whether each BioThrax lot was shipped within the FDA approved temperature range.
|
|
e)
|
Contractor shall submit all lot documentation as required under Section F.3.2 below for the lot(s) to be delivered.
|
|
a.
|
SNS evaluation of these documents will be completed in accordance with Section E.4.2 above.
|
|
CLIN
|
Delivery Period
|
# of Doses
|
|
0001
|
October 1, 2011 to September 30, 2012
|
[**]
|
|
0002
|
October 1, 2012 to September 30, 2013
|
[**]
|
|
0003
|
October 1, 2013 to September 30, 2014
|
[**]
|
|
0004
|
October 1, 2014 to September 30, 2015
|
[**]
|
|
0005
|
October 1, 2015 to September 30, 2016
|
[**]
|
|
a.
|
At least [**] business days prior to each product pick up by the SNS, the Contractor shall provide to the Contracting Officer and COR:
|
|
i.
|
The delivery date:
|
|
i.
|
For FOB Origin deliveries, shall be the date the product will be ready for loading on the truck(s) scheduled by the SNS
|
|
ii.
|
For FOB Destination deliveries, shall be the date the product will arrive at the SNS designated delivery location
|
|
ii.
|
Physical address of the product pick up location (facility name, address, point of contact name and telephone number)
|
|
iii.
|
Certificate(s) of Analysis
|
|
iv.
|
FDA Lot Release(s)
|
|
v.
|
Forecasted number of 40”x48” pallets, number of vials, and doses to be loaded
|
|
b.
|
At least [**] hours before each scheduled pick up by the SNS the Contractor shall provide the following to the Contracting Officer and COR:
|
|
i.
|
Packing Slip
|
|
ii.
|
Actual number of pallets, vials and doses to be loaded
|
|
iii.
|
Diagram of product shipment pallet (how many vials per box, per pallet)
|
|
c.
|
Within [**] hours after the product has been picked up by the Government, the Contract shall provide to the Contracting Officer and COR the remaining ambient exposure time letter disclosing temperature control until the point that SNS (or SNS-designated personnel) assumed responsibility for temperature control, per Section E.3, for each lot from the Contractor’s Quality Department. The letter should indicate that the product was manufactured and released in accordance with cGMP and has met all acceptance criteria to allow for government distribution.
|
|
a.
|
The Contractor shall participate in a quarterly meeting (teleconference and/or face-to-face) to discuss performance under the contract. These meetings should provide status updates and discuss on-going manufacturing, clinical, regulatory, and shipment issues as applicable. These meetings shall be coordinated by the COR and/or Contracting Officer.
|
|
b.
|
Risk Mitigation Plan: The risk mitigation plan should identify manufacturing, quality, regulatory, and shipment risks and countermeasures to mitigate these risks. This plan should be updated annually or as deemed necessary by the Government .
|
|
c.
|
Additional reporting requirements:
|
|
1.
|
Contractor will notify DSNS in its quarterly reports if Contractor undertakes post-marketing commitments for Phase 4 studies in the event of emergency use authorization.
|
|
2.
|
Contractor will provide DSNS with drafts of supplements to its BLA for BioThrax® that are material to the manufactured product and to the contract.
|
|
|
(b) The contractor shall simultaneously submit an invoice/voucher via email to the cognizant contracting officer at cnp9@cdc.gov and to the cognizant CDC Contracting Officer’s Representatives at gtv4@cdc.gov and bmk7@cdc.gov.
|
|
(6)
|
Contract Line Item Number and Description of Item
|
|
(9)
|
Shipping and Payment Terms
|
|
(10)
|
Total Amount of Invoice
|
|
(13)
|
DUNS + 4 Number
|




|
FAR Ref
|
Date
|
Title
|
|
52.203-3
|
Apr-84
|
Gratuities
|
|
52.204-4
|
May-11
|
Printed or Copied Double-Sided on Postconsumer Fiber Content Paper
|
|
52.227-1
|
Dec-07
|
Authorization and Consent
|
|
52.227-2
|
Dec-07
|
Notice and Assistance Regarding Patent and Copyright Infringement
|
|
52.229-3
|
Apr-03
|
Federal, State, and Local Taxes
|
|
52.232-11
|
Apr-84
|
Extras
|
|
52.232-18
|
Apr-84
|
Availability of Funds
|
|
52.223-3
|
Jan-97
|
Hazardous Material Identification and Material Safety Data.
|
|
52.233-4
|
Oct-04
|
Applicable Law for Breach of Contract Claim
|
|
52.242-13
|
Jul-95
|
Bankruptcy
|
|
52.243-1
|
Aug-87
|
Changes - Fixed-Price
|
|
52.244-5
|
Dec-96
|
Competition in Subcontracting
|
|
52.245-1
|
Aug-10
|
Government Property
|
|
52.245-9
|
Aug-10
|
Uses and Charges
|
|
52.247-30
|
Feb-06
|
F.O.B. Origin, Contractor’s Facility
|
|
52.247-34
|
Nov-91
|
F.O.B. Destination
|
|
52.249-2
|
May-04
|
Termination for the Convenience of the Government (Fixed-Price)
|
|
52.249-8
|
Apr-84
|
Default (Fixed-Price Supply and Service)(Over the Simplified Acquisition Threshold)
|
|
352.201-70
|
Jan-06
|
Paperwork Reduction Act
|
|
352.202-1
|
Jan-06
|
Definitions
|
|
352.203-70
|
Jan-06
|
Anti-Lobbying (Over Simplified Acquisition Threshold)
|
|
352.222-70
|
Jan-10
|
Contractor Cooperation in Equal Employment Opportunity Investigations
|
|
352.223-70
|
Jan-06
|
Safety and Health
|
|
352.227-70
|
Jan-06
|
Publications and Publicity
|
|
352.231-71
|
Jan-01
|
Pricing of Adjustments
|
|
352.242-73
|
Jan-06
|
Withholding of Contract Payments
|
|
352.270-4
|
Jan-06
|
Protection of Human Subjects
|
|
352.270-5
|
Jan-06
|
Care of Laboratory Animals
|

|
|
Section K - Representations, Certifications, and Other Statements of Offerors
|
|
(a)
|
All Contractors are required to complete electronic annual representations and certifications at http://orca.bpn.gov in conjunction with registration in the Central Contractor Registration (CCR) database per FAR 4.1102 and FAR 4.1201. Certifications in ORCA are required prior to the submission of contract proposals.
|
|
|
(b)
|
Contractors shall update the representations and certifications submitted to ORCA as necessary, but at least annually, to ensure they are kept current, accurate, and complete. All Contractors with current contracts shall notify the Contracting Officer in writing when changes are made to ORCA. The representations and certifications are effective until one year from date of submission or update to ORCA.
|
|
a.
|
Identify the total amount of all presently active federal contracts/cooperative agreements/grants and commercial agreements citing the committed levels of effort for those projects for each of the key individuals* in this proposal.
|
|
|
Professional’s Name and Title/Position:
|
|
Identifying Number
|
Agency
|
Total Effort Committed
|
|
b.
|
Provide the total number of outstanding proposals, exclusive of the instant proposal, having been submitted by your organization, not presently accepted but in an anticipatory stage, which will commit levels of effort by the proposed professional individuals*.
|
|
|
Professional’s Name and Title/Position:
|
|
Identifying Number
|
Agency
|
Total Effort Committed
|
|
C.
|
Provide a statement of the level of effort to be dedicated to any resultant contract awarded to your organization for those individuals designated and cited in this proposal.
|
|
Name
|
Title/Position
|
Total Proposed Effort
|
|
Policy. Research activities involving human subjects may not be conducted or supported by the Departments and Agencies adopting the Common Rule (56FR28003, June 18, 1991) unless the activities are exempt from or approved in accordance with the Common Rule. See section 101(b) of the Common Rule for exemptions. Institutions submitting applications or proposals for support must submit certification of appropriate Institutional Review Board (IRB) review and approval to the Department or Agency in accordance with the Common Rule.
|
Institutions must have an assurance of compliance that applies to the research to be conducted and should submit certification of IRB review and approval with each application or proposal unless otherwise advised by the Department or Agency.
|
|
1. Request Type
ORIGINAL
CONTINUATION
EXEMPTION
|
2. Type of Mechanism
GRANT CONTRACT FELLOWSHIP
COOPERATIVE AGREEMENT
OTHER
|
3. Name of Federal Department or Agency and, if known, Application or Proposal Identification No.
|
|
4. Title of Application or Activity
|
5. Name of Principal Investigator, Program Director, Fellow, or Other
|
|
|
|
No assurance has been filed for this institution. This institution declares that it will provide an Assurance and Certification of IRB review and approval upon request.
|
|
|
Exemption Status: Human subjects are involved, but this activity qualifies for exemption under Section 101(b), paragraph _____.
|
|
|
by: Full IRB Review on (date of IRB meeting) ______________ or Expedited Review on (date)
|
|
|
If less than one year approval, provide expiration date ______________________
|
|
|
This activity contains multiple projects, some of which have not been reviewed. The IRB has granted approval on condition that all projects covered by the Common Rule will be reviewed and approved before they are initiated and that appropriate further certification will be submitted.
|
|
9. The official signing below certifies that the information provided above is correct and that, as required, future reviews will be performed until study closure and certification will be provided.
|
10. Name and Address of Institution
|
|
|
11. Phone No. (with area code)
|
||
|
12. Fax No. (with area code)
|
||
|
13. Email:
|
||
|
14. Name of Official
|
15. Title
|
|
|
16. Signature
|
Date
|
|
|
Box 2:
|
Check Type of Award Mechanism: Grant, Contract, Cooperative Agreement, Fellowship, Other
|
|
Box 7:
|
For Certification of IRB Review, if an Assurance is on file (that is, if Option 1 or 2 was selected in Box 6), two options for response are provided.
|
|
1. Type of Federal Action:
a. contract
b. grant
c. cooperative agreement
d. loan
e. loan guarantee
f. loan insurance
|
2. Status of Federal Action:
a. bid/offer/application
b. initial award
c. post-award
|
3. Report Type:
a. initial filing
b. material change
For Material Change Only:
year ________ quarter ________
date of last report _____________
|
|
|
4. Name and Address of Reporting Entity:
Prime Subawardee
Tier _______, if known:
Congressional District, if known: 4c
|
5. If Reporting Entity in No. 4 is a Subawardee, Enter Name and Address of Prime:
Congressional District, if known:
|
||
|
6. Federal Department/Agency:
|
7. Federal Program Name/Description:
CFDA Number, if applicable: _____________
|
||
|
8. Federal Action Number, if known:
|
9. Award Amount, if known:
$
|
||
|
10. a. Name and Address of Lobbying Registrant
(if individual, last name, first name, MI):
|
b. Individuals Performing Services (including address if different from No. 10a)
(last name, first name, MI):
|
||
|
11.Information requested through this form is authorized by title 31 U.S.C. section 1352. This disclosure of lobbying activities is a material representation of fact upon which reliance was placed by the tier above when this transaction was made or entered into. This disclosure is required pursuant to 31 U.S.C. 1352. This information will be available for public inspection. Any person who fails to file the required disclosure shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for each such failure.
|
Signature:
Print Name:
Title:
Telephone No.: Date:
|
||
|
Federal Use Only:
|
Authorized for Local Reproduction
Standard Form LLL (Rev. 7-97)
|
||
|
|
1.
|
Identify the type of covered Federal action for which lobbying activity is and/or has been secured to influence the outcome of a covered Federal action.
|
|
|
2.
|
Identify the status of the covered Federal action.
|
|
|
3.
|
Identify the appropriate classification of this report. If this is a followup report caused by a material change to the information previously reported, enter the year and quarter in which the change occurred. Enter the date of the last previously submitted report by this reporting entity for this covered Federal action.
|
|
|
4.
|
Enter the full name, address, city, State and zip code of the reporting entity. Include Congressional District, if known. Check the appropriate classification of the reporting entity that designates if it is, or expects to be, a prime or subaward recipient. Identify the tier of the subawardee, e.g., the first subawardee of the prime is the 1st tier. Subawards include but are not limited to subcontracts, subgrants and contract awards under grants.
|
|
|
5.
|
If the organization filing the report in item 4 checks “Subawardee,” then enter the full name, address, city, State and zip code of the prime Federal recipient. Include Congressional District, if known.
|
|
|
6.
|
Enter the name of the Federal agency making the award or loan commitment. Include at least one organizational level below agency name, if known. For example, Department of Transportation, United States Coast Guard.
|
|
|
7.
|
Enter the Federal program name or description for the covered Federal action (item 1). If known, enter the full Catalog of Federal Domestic Assistance (CFDA) number for grants, cooperative agreements, loans, and loan commitments.
|
|
|
8.
|
Enter the most appropriate Federal identifying number available for the Federal action identified in item 1 (e.g., Request for Proposal (RFP) number; Invitation for Bid (IFB) number; grant announcement number; the contract, grant, or loan award number; the application/proposal control number assigned by the Federal agency). Include prefixes, e.g., “RFP-DE-90-001.”
|
|
|
9.
|
For a covered Federal action where there has been an award or loan commitment by the Federal agency, enter the Federal amount of the award/loan commitment for the prime entity identified in item 4 or 5.
|
|
|
10.
|
(a)
|
Enter the full name, address, city, State and zip code of the lobbying registered under the Lobbying
|
|
|
Act of 1995 engaged by the reporting entity identified in item 4 to influence the covered Federal
|
|
|
action.
|
|
|
(b)
|
Enter the full names of the individual(s) performing services, and include full address if different
|
|
|
from 10(a). Enter Last Name, First Name, and Middle Initial (MI).
|
|
|
11.
|
The certifying official shall sign and date the form, print his/her name, title, and telephone number.
|
|
PRIVACY ACT STATEMENT
|
|
The following information is provided to comply with the Privacy Act of 1974 (P.L. 93-579). All information collected on this form is required under the provisions of 31 U.S.C. 3322 and 31 CFR 210. This information will be used by the Treasury Department to transmit payment data, by electronic means to vendor’s financial institution. Failure to provide the requested information may delay or prevent the receipt of payments.
|
|
AGENCY INFORMATION
|
||
|
FEDERAL PROGRAM AGENCY
Centers for Disease Control & Prevention
|
||
|
AGENCY IDENTIFIER:
CDC
|
AGENCY LOCATION CODE (ALC):
7509-0421
|
ACH FORMAT:
CCD+ CTX CTP
|
|
ADDRESS
P. O. Box 15580, MS D06
|
||
|
Atlanta, GA 30333
|
||
|
CONTACT PERSON:
Customer Service
|
TELEPHONE NUMBER:
(404) 718-8100
|
|
|
ADDITIONAL INFORMATION
FAX: (404) 638-5342
|
||
|
PAYEE/COMPANY INFORMATION
|
||
|
PAYEE/COMPANY NAME:
|
SSN or TAXPAYER ID NO.
|
|
|
ADDRESS:
|
DUNS+4 NUMBER
|
|
|
CITY
|
STATE
|
ZIP
|
|
CONTACT PERSON/NAME:
|
TELEPHONE NUMBER:
|
|
|
FINANCIAL INSTITUTION INFORMATION
|
|||
|
FINANCIAL INSTITUTION NAME:
|
|||
|
ADDRESS (OR BRANCH):
|
|||
|
CITY:
|
STATE:
|
ZIP:
|
|
|
NINE-DIGIT ROUTING TRANSIT NUMBER:
|
|||
|
DEPOSITOR ACCOUNT NUMBER:
|
|||
|
TYPE OF ACCOUNT:
CHECKING SAVINGS
|
|||
|
ACH COORDINATOR NAME OR AUTHORIZED OFFICIAL AT FINANCIAL INSTITUTION (NOT REQUIRED):
|
TELEPHONE NUMBER:
|
||
|
CDC 0.4433 (E), CDC Adobe Acrobat 9.0, S508 Electronic Version, January 2009
|
|||
|
DATE OF PLAN: _____________
|
|
CONTRACTOR:
|
|
ADDRESS:
|
|
DUN & BRADSTREET NUMBER:
|
|
SOLICITATION OR CONTRACT NUMBER:
|
|
ITEM/SERVICE (Description):
|
|
TOTAL CONTRACT AMOUNT:$_______________________________
Total contract or Base-Year, if options
$_____________ $_________________ $______________ $_____________
Option #1 Option #2 Option #3 Option #4
(if applicable) (if applicable) (if applicable) (if applicable)
|
|
TOTAL MODIFICATION AMOUNT, IF APPLICABLE $
|
|
TOTAL TASK ORDER AMOUNT, IF APPLICABLE $
|
|
PERIOD OF CONTRACT PERFORMANCE (Month, Day & Year):
|
|
|
[ ]
|
Individual plan (all elements developed specifically for this contract and applicable for the full term of this contract).
|
|
|
[ ]
|
Master plan (goals developed for this contract) all other elements standardized and approved by a lead agency Federal Official; must be renewed every three years and contractor must provide copy of lead agency approval.
|
|
|
[ ]
|
Commercial products/service plan This plan is used when the contract sells products and services customarily used for non-government purposes. Plan/goals are negotiated with the initial agency on a company-wide basis rather than for individual contracts. The plan is effective only during the year approved. The contractor must provide a copy of the initial agency approval, and must submit an annual SF-295 to HHS with a breakout of subcontracting prorated for HHS (with an OPDIV breakdown, if possible).
|
|
|
a.
|
Total estimated dollar value of ALL planned subcontracting, i.e., with ALL types of concerns under this contract is $_______________________ (b + h = a) (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
b.
|
Total estimated dollar value and percent of planned subcontracting with SMALL BUSINESSES (including SDB, WOSB, HUBZone, VOSB, and SDVOSB):
|
|
|
(% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
c.
|
Total estimated dollar and percent of planned subcontracting with SMALL DISADVANTAGED BUSINESSES: (% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
d.
|
Total estimated dollar and percent of planned subcontracting with WOMEN-OWNED SMALL BUSINESSES: (% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
e.
|
Total estimated dollar and percent of planned subcontracting with HUBZone SMALL BUSINESSES:
|
|
|
(% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
f.
|
Total estimated dollar and percent of planned subcontracting with VETERAN SMALL BUSINESSES:
|
|
|
(% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
g.
|
Total estimated dollar and percent of planned subcontracting with SERVICE-DISABLED VETERAN SMALL BUSINESSES:
|
|
|
(% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
h.
|
Total estimated dollar and percent of planned subcontracting with “OTHER THAN SMALL BUSINESSES”:
|
|
|
(% of “a”) $____________ and _____% (Base Year)
|
|
FY-_____(1st Option)
$________&_____%
|
FY-_____(2nd Option)
$________&_____%
|
FY-_____(3rd Option)
$________&_____%
|
FY-_____(4th Option)
$________&_____%)
|
|
|
1.
|
Federal Prime contract goals
|
|
|
SB equals 30.32%; SDB equals 11.12%; HUBZone equals 3.03%, WOSB equals 5.05% and SDVOSB equals 3%, VOSB equals 3% and can serve as objectives for subcontracting goal development.
|
|
|
2.
|
SDB, WOSB, HUBZone, SDVOSB and VOSB goals are subsets of SB and should be counted and reported in multiple categories, as appropriate.
|
|
|
3.
|
If any contract has more than four options, please attach additional sheets showing dollar amounts and percentages.
|
|
|
i.
|
Provide a description of ALL the products and/or services to be subcontracted under this contract, and indicate the size and type of business supplying them (check all that apply).
|
|
Product/Service
|
Other
|
SB
|
SDB
|
WOSB
|
HUBZoneSB
|
VOSB
|
SDVOSB
|
|
|
j.
|
Provide a description of the method used to develop the subcontracting goals for SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns. Address efforts made to ensure that maximum practicable subcontracting opportunities have been made available for those concerns and explain the method used to identify potential sources for solicitation purposes. Explain the method and state the quantitative basis (in dollars) used to establish the percentage goals. Also, explain how the areas to be subcontracted to SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns were determined, how the capabilities of these concerns were considered for subcontract opportunities and how such data comports with the cost proposal. Identify any source lists or other resources used in the determination process. (Attach additional sheets, if necessary.)
|
|
|
k.
|
Indirect costs have [ ] have not [ ] been included in the dollar and percentage subcontracting goals above (check one).
|
|
|
l.
|
If indirect costs have been included, explain the method used to determine the proportionate share of such costs to be allocated as subcontracts to SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns.
|
|
|
a.
|
Develops and promotes company-wide policy initiatives that demonstrate the company’s support for awarding contracts and subcontracts to SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns; and assures that these concerns are included on the source lists for solicitations for products and services they are capable of providing; [ ] yes [ ] no
|
|
|
b.
|
Develops and maintains bidder source lists of SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns from all possible sources; [ ] yes [ ] no
|
|
|
c.
|
Ensures periodic rotation of potential subcontractors on bidder’s lists; [ ] yes [ ] no
|
|
|
d.
|
Ensures that SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB businesses are included on the bidders’ list for every subcontract solicitation for products and services that they are capable of providing; [ ] yes [ ] no
|
|
|
e.
|
Ensures that Requests for Proposals (RFPs) are designed to permit the maximum practicable participation of SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns; [ ] yes [ ] no
|
|
|
f.
|
Reviews subcontract solicitations to remove statements, clauses, etc., which might tend to restrict or prohibit SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB participation; [ ] yes [ ] no
|
|
|
g.
|
Accesses various sources for the identification of SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns to include the Central Contractor Registration’s (CCR) web site at (http://www.ccr.gov), the National Minority Purchasing Council Vendor Information Service, the Office of Minority Business Data Center in the Department of Commerce, local small business and minority associations, contact with local chambers of commerce and Federal agencies’ Small Business Offices; [ ] yes [ ] no
|
|
|
h.
|
Establishes and maintains contract and subcontract award records; [ ] yes [ ] no
|
|
|
i.
|
Participates in Business Opportunity Workshops, Minority Business Enterprise Seminars, Trade Fairs, Procurement Conferences, etc; [ ] yes [ ] no
|
|
|
j.
|
Ensures that SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB concerns are made aware of subcontracting opportunities and assisting concerns in preparing responsive bids to the company; [ ] yes [ ] no
|
|
|
k.
|
Conducts or arranges for the conduct of training for purchasing personnel regarding the intent and impact of Section 8(d) of the Small Business Act, as amended; [ ] yes [ ] no
|
|
|
l.
|
Monitors the company’s subcontracting program performance and makes any adjustments necessary to achieve the subcontract plan goals; [ ] yes [ ] no
|
|
|
m.
|
Prepares and submits timely, required subcontract reports; [ ] yes [ ] no
|
|
|
n.
|
Coordinates the company’s activities during the conduct of compliance reviews by Federal agencies; [ ] yes [ ] no; and
|
|
|
o.
|
Other duties:
|
|
|
a.
|
Outreach efforts to obtain sources:
|
|
|
1.
|
Contacting minority and small business trade associations; 2) contacting business development organizations and local chambers of commerce; 3) attending SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB procurement conferences and trade fairs; 4) requesting sources from the Central Contractor Registration’s (CCR) web site at (hhtp://www.ccr.gov) and other SBA and Federal agency resources. Contractors may also conduct market surveys to identify new sources, to include, assessing the NIH e-Portals in Commerce, (e-PIC), (http://epic.od.nih.gov/). The NIH e-Portals in Commerce is not a mandatory source and may be used at the offeror’s discretion.
|
|
|
b.
|
Internal efforts to guide and encourage purchasing personnel:
|
|
|
1.
|
Conducting workshops, seminars, and training programs;
|
|
|
2.
|
Establishing, maintaining, and utilizing SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB source lists, guides, and other data for soliciting subcontractors; and
|
|
|
3.
|
Monitoring activities to evaluate compliance with the subcontracting plan.
|
|
|
c.
|
Additional efforts:
|
|
Reporting Period
|
Report Due
|
Due Date
|
|
Oct 1 – Mar 3
|
SF-294
|
4/30
|
|
Apr 1 – Sept 30
|
SF-294
|
10/30
|
|
Oct 1 – Sept 30
|
SF-295
|
10/30
|
|
Contract Completion
|
OF-312
|
30 days after completion
|
|
|
a.
|
Submit SF-294 to cognizant Awarding Contracting Officer.
|
|
|
b.
|
Submit Optional Form 312, (OF-312), if applicable, to cognizant Awarding Contracting Officer.
|
|
|
c.
|
Submit SF-295 to cognizant Awarding Contracting Officer and to the:
|
|
|
d.
|
Submit “information” copy of the SF-295 and the SF-294 upon request to the SBA Commercial Market Representative (CMR); visit the SBA at http://www.sba.gov/gc and click on assistance directory to locate your nearest CMR.
|
|
|
a.
|
SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB source lists, guides and other data identifying such vendors;
|
|
|
b.
|
Organizations contacted in an attempt to locate SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB sources;
|
|
|
c.
|
On a contract-by-contract basis, records on all subcontract solicitations over $100,000, which indicate for each solicitation (1) whether SB, SDB, WOSB, HUBZone, VOSB, and/or SDVOSB concerns were solicited, if not, why not and the reasons solicited concerns did not receive subcontract awards.
|
|
|
d.
|
Records to support other outreach efforts, e.g., contacts with minority and small business trade associations, attendance at small and minority business procurement conferences and trade fairs;
|
|
|
e.
|
Records to support internal guidance and encouragement provided to buyers through (1) workshops, seminars, training programs, incentive awards; and (2) monitoring performance to evaluate compliance with the program and requirements; and
|
|
|
f.
|
On a contract-by-contract basis, records to support subcontract award data including the name, address, and business type and size of each subcontractor. (This item is not required on a contract-by-contract basis for company or division-wide commercial plans.)
|
|
|
g.
|
Other records to support your compliance with the subcontracting plan: (Please describe)
|